Biotech India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.41 M
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.09 Cr
- Revenue Growth -8.40%
- Profit Growth -7.55%
- Ebitda -10.01%
- Net Worth 8.88%
- Total Assets 5.97%
About Biotech India
Biotech India Limited (BIL) is a Public Limited Indian Non-Government Company incorporated in India on 05 May 1994 and has a history of 30 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.41 M.
The company currently has active open charges totaling ₹9.09 Cr.
Ajay Swarup, Madhavi Swarup, and Shekhar Swarup serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1994PLC058812
-
Company No.
058812
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
05 May 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Biotech India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Swarup
|
Director | 14-Aug-2019 | Current |
|
Madhavi Swarup
|
Director | 05-May-1994 | Current |
|
Shekhar Swarup
|
Director | 28-Mar-2017 | Current |
Financial Performance of Biotech India.
Biotech India Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.4% decrease. The company also saw a slight decrease in profitability, with a 7.55% decrease in profit. The company's net worth moved up by a moderate rise of 8.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech India?
In 2020, Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Globus Spirits LimitedAjay Swarup and Shekhar Swarup are mutual person
-
Gras Education & Training Services Private LimitedAjay Swarup is a mutual person
-
Ram Bagh Facility Services LlpAjay Swarup and Shekhar Swarup are mutual person
-
Globus Ansa Private Limited
Ajay Swarup and Shekhar Swarup are mutual person
-
Himalayan Spirits Limited
Ajay Swarup, Madhavi Swarup and 1 more are mutual person
-
Chandbagh Investments Limited
Ajay Swarup, Madhavi Swarup and 1 more are mutual person
Charges (Loans)
₹90.90 M
₹0
Charges Breakdown by Lending Institutions
- Others : 9.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2023 | Others | ₹4.39 Cr | Open |
| 13 Feb 2019 | Others | ₹9.40 M | Open |
| 28 Dec 2017 | Others | ₹3.76 Cr | Open |
How Many Employees Work at Biotech India?
Unlock and access historical data on people associated with Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
